A dynamic model of poliomyelitis outbreaks: learning from the past to help inform the future.

Policy-makers now face important questions regarding the tradeoffs among different strategies for managing poliomyelitis risks after they succeed with polio eradication. To estimate the potential consequences of reintroductions of polioviruses and the resulting outbreaks, the authors developed a dynamic disease transmission model that can simulate many aspects of outbreaks for different posteradication conditions. In this paper, the authors identify the issues related to prospective modeling of future outbreaks using such a model, including the reality that accurate prediction of conditions and associated model inputs prior to future outbreaks remains challenging. The authors explored the model's behavior in the context of three recent outbreaks resulting from importation of poliovirus into previously polio-free countries and found that the model reproduced reported data on the incidence of cases. The authors expect that this model can provide important insights into the dynamics of future potential poliomyelitis outbreaks and in this way serve as a useful tool for risk assessment.

[1]  Lilly Yuen,et al.  Circulation of Type 1 Vaccine-Derived Poliovirus in the Philippines in 2001 , 2004, Journal of Virology.

[2]  Jim Koopman,et al.  Modeling infection transmission. , 2004, Annual review of public health.

[3]  W. Dowdle,et al.  Will containment of wild poliovirus in laboratories and inactivated poliovirus vaccine production sites be effective for global certification? , 2004, Bulletin of the World Health Organization.

[4]  R. Leke,et al.  Certification of polio eradication: process and lessons learned. , 2004, Bulletin of the World Health Organization.

[5]  S. Cochi,et al.  Framework for evaluating the risks of paralytic poliomyelitis after global interruption of wild poliovirus transmission. , 2004, Bulletin of the World Health Organization.

[6]  P. Fine,et al.  Polio control after certification: major issues outstanding. , 2004, Bulletin of the World Health Organization.

[7]  Francis Delpeyroux,et al.  Circulating vaccine-derived polioviruses: current state of knowledge. , 2004, Bulletin of the World Health Organization.

[8]  Kimberly M Thompson,et al.  Policy decision options during the first 5 years following certification of polio eradication. , 2003, MedGenMed : Medscape general medicine.

[9]  C. Bellamy The State of the World's Children 2003 , 2003 .

[10]  M. Roivainen,et al.  Serotype-specific mucosal immune response and subsequent poliovirus replication in vaccinated children. , 2003, Journal of medical virology.

[11]  M. Pallansch,et al.  Circulation of Endemic Type 2 Vaccine-Derived Poliovirus in Egypt from 1983 to 1993 , 2003, Journal of Virology.

[12]  M. Pallansch,et al.  Outbreak of Poliomyelitis in Hispaniola Associated with Circulating Type 1 Vaccine-Derived Poliovirus , 2002, Science.

[13]  R. Sutter,et al.  Sabin monovalent oral polio vaccines: review of past experiences and their potential use after polio eradication. , 2001, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  C. D. Quadros,et al.  Brote de poliomielitis en Haití y la República Dominicana debido a un virus derivado de la vacuna antipoliomielítica oral , 2001 .

[15]  S. Arya Immunity to Poliomyelitis in the Netherlands , 2001 .

[16]  P. Fine,et al.  Stopping a polio outbreak in the post-eradication era. , 2001, Developments in biologicals.

[17]  T. Kimman,et al.  Immunity to poliomyelitis in The Netherlands. , 2001, American journal of epidemiology.

[18]  P E Fine,et al.  Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative. , 1999, American journal of epidemiology.

[19]  B. Prabhakar,et al.  Direct Detection of Sabin Poliovirus Vaccine Strains in Stool Specimens of First-Dose Vaccinees by a Sensitive Reverse Transcription-PCR Method , 1999, Journal of Clinical Microbiology.

[20]  L. Fiore,et al.  Antigenic and Molecular Characterization of Wild Type 1 Poliovirus Causing Outbreaks of Poliomyelitis in Albania and Neighboring Countries in 1996 , 1998, Journal of Clinical Microbiology.

[21]  M. L. Ciofi Degli Atti,et al.  Outbreak of paralytic poliomyelitis in Albania, 1996: high attack rate among adults and apparent interruption of transmission following nationwide mass vaccination. , 1998, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[22]  P. Ogra,et al.  Mucosal responses to parenteral and mucosal vaccines. , 1998, Developments in biological standardization.

[23]  M. Pallansch,et al.  Duration of poliovirus excretion and its implications for acute flaccid paralysis surveillance: a review of the literature. , 1997, The Journal of infectious diseases.

[24]  W. Dowdle,et al.  The Biologic Principles of Poliovirus Eradication , 1997, The Journal of infectious diseases.

[25]  R. Sutter,et al.  Outbreaks of paralytic poliomyelitis, 1976-1995. , 1997, The Journal of infectious diseases.

[26]  C. Meschievitz,et al.  Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group. , 1997, The Journal of infectious diseases.

[27]  W. Dowdle,et al.  Poliovirus surveillance: building the global Polio Laboratory Network. , 1997, The Journal of infectious diseases.

[28]  J. Melnick Poliovirus and Other Enteroviruses , 1997 .

[29]  M. Pallansch,et al.  Seroprevalence of antibody against poliovirus in inner-city preschool children. Implications for vaccination policy in the United States. , 1996, JAMA.

[30]  K Dietz,et al.  Eradication of poliomyelitis: when can one be sure that polio virus transmission has been terminated? , 1996, American journal of epidemiology.

[31]  Valerie Isham,et al.  Models for Infectious Human Diseases: Their Structure and Relation to Data , 1996 .

[32]  K. Hadeler,et al.  Models for Infectious Human Diseases: Stochastic models for the eradication of poliomyelitis: minimum population size for polio virus persistence , 1996 .

[33]  A. V. van Loon,et al.  Poliomyelitis in the Netherlands: a review of population immunity and exposure between the epidemics in 1978 and 1992 , 1995, Epidemiology and Infection.

[34]  K. Hadeler,et al.  Deterministic models for the eradication of poliomyelitis: vaccination with the inactivated (IPV) and attenuated (OPV) polio virus vaccine. , 1995, Mathematical biosciences.

[35]  M. Mulders,et al.  Poliomyelitis outbreak in an unvaccinated community in the Netherlands, 1992-93 , 1994, The Lancet.

[36]  J. Andrus,et al.  Lessons from Cuba: mass campaign administration of trivalent oral poliovirus vaccine and seroprevalence of poliovirus neutralizing antibodies. , 1994, Bulletin of the World Health Organization.

[37]  S. Lo Caputo,et al.  Seroimmunity to poliomyelitis in an Albanian immigrant population. , 1992, Vaccine.

[38]  P. Wright,et al.  Factors affecting the immunogenicity of oral poliovirus vaccine in developing countries: review. , 1991, Reviews of infectious diseases.

[39]  R. May,et al.  Infectious Diseases of Humans: Dynamics and Control , 1991, Annals of Internal Medicine.

[40]  L. M. Onotato MUCOSAL IMMUNITY INDUCED BY ENHANCED POTENCY INACTIVATED AND ORAL POLIO VACCINES , 1991 .

[41]  J. Cuthie,et al.  Serologic response to oral polio vaccine and enhanced-potency inactivated polio vaccines. , 1988, American journal of epidemiology.

[42]  R. Bernier Some observations on poliomyelitis lameness surveys. , 1984, Reviews of infectious diseases.

[43]  S. You,et al.  Epidemiological aspects of a poliomyelitis outbreak in Taiwan, 1982. , 1984, Annals of the Academy of Medicine, Singapore.

[44]  B Cvjetanović,et al.  Epidemiological models of poliomyelitis and measles and their application in the planning of immunization programmes. , 1982, Bulletin of the World Health Organization.

[45]  N. Nathanson,et al.  The epidemiology of poliomyelitis: enigmas surrounding its appearance, epidemicity, and disappearance. , 1979, American journal of epidemiology.

[46]  L. Stanberry,et al.  Preface to the fifth edition , 2014 .

[47]  A. Langworthy,et al.  An influenza simulation model for immunization studies. , 1976, American journal of epidemiology.

[48]  E Ackerman,et al.  Stochastic two-agent epidemic simulation models for a community of families. , 1971, American journal of epidemiology.

[49]  Y. Ghendon,et al.  Comparison of the Resistance of the Intestinal Tract to Poliomyelitis virus (Sabin's Strains) in Persons after Naturally and Experimentally Acquired Immunity. , 1961 .

[50]  L. Elveback,et al.  Studies on the development of natural immunity to poliomyelitis in Louisiana. V. Passive transfer of polioantibody from mother to fetus, and natural decline and disappearance of antibody in the infant. , 1960, Journal of immunology.

[51]  J. Fox,et al.  Studies on the development of natural immunity to poliomyelitis in Louisiana. II. Description and analysis of episodes of infection observed in study group households. , 1957, American journal of hygiene.

[52]  Serfling Re,et al.  Historical review of epidemic theory. , 1952 .

[53]  J. Paul,et al.  The incubation period in human poliomyelitis and its implications. , 1947, Journal of the American Medical Association.